Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Maruzzo

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Clinical Genitourinary Cancer|March 11, 2023
Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease ModelAlessandra Buja, Giuseppe De Luca, Maura Gatti, et al.
Biomedicines|October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell CarcinomaMartina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
BMC Urology|December 19, 2022
Renal cell carcinoma: the population, real world, and cost-of-illnessAlessandra Buja, Giuseppe De Luca, Maura Gatti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2024
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working groupAngela Toss, Claudia Piombino, Paola Quarello, et al.
Medicine|October 28, 2024
Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literatureSalim Jubran, Umberto Basso, Anna Milani, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in ItalyElena Verzoni, Giovanni Pappagallo, Filippo Alongi, et al.
Frontiers in Oncology|December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Anticancer Research|October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective AnalysisGerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.
Clinical Sarcoma Research|April 24, 2015
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access programAttila Kollàr, Marco Maruzzo, Christina Messiou, et al.
Targeted Oncology|December 11, 2021
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell CarcinomaVeronica Mollica, Matteo Santoni, Marc R Matrana, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Clinical Genitourinary Cancer|March 11, 2023
Estimated Direct Costs of Renal Cancer by Stage of Disease at Diagnosis and Phase of Its Management: A Whole-Disease ModelAlessandra Buja, Giuseppe De Luca, Maura Gatti, et al.
Biomedicines|October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell CarcinomaMartina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
BMC Urology|December 19, 2022
Renal cell carcinoma: the population, real world, and cost-of-illnessAlessandra Buja, Giuseppe De Luca, Maura Gatti, et al.
European Journal of Cancer (Oxford, England : 1990)|October 3, 2024
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working groupAngela Toss, Claudia Piombino, Paola Quarello, et al.
Medicine|October 28, 2024
Skin metastasis of BRCA mutated prostate cancer: A case report and a brief review of literatureSalim Jubran, Umberto Basso, Anna Milani, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in ItalyElena Verzoni, Giovanni Pappagallo, Filippo Alongi, et al.
Frontiers in Oncology|December 13, 2021
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, et al.
Anticancer Research|October 1, 2021
Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma - A Single Centre Retrospective AnalysisGerard M Walls, Shane H Zaidi, Nicos Fotiadis, et al.
Clinical Sarcoma Research|April 24, 2015
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: a report of the UK managed access programAttila Kollàr, Marco Maruzzo, Christina Messiou, et al.
Targeted Oncology|December 11, 2021
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell CarcinomaVeronica Mollica, Matteo Santoni, Marc R Matrana, et al.
Pageof 15